Looking to publish in Current Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCurrent Gene Therapy is a journal in gene therapy with ISSN 1566-5232 (print) and 1875-5631 (online). It has an Impact Factor of 3.3, is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed, and publishes Volume 26 in 2026. The journal offers online manuscript submission and includes both subscription content and open access articles.
Looking to publish in Current Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Current Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Mini-Reviews
Systematic Reviews
Meta-Analyses
Research Articles
Randomized Drug Clinical Trial Studies
Short Communications
Letters
Case Reports
Recent Publications
Effect of Source and Time of Collection on rAAV9 Production Yield and Quality: A Comparative Bioprocess Analysis
Kadarkarai Raj Rajendran, Sharath Babu G.R, Ravikiran Macherla, Arkasubhra Ghosh
SMART Nanocarriers for siRNA Delivery: Stimuli-Responsive Platforms for Targeted Gene Silencing
Nagashree D, Manisha S Jain, Harshitha K S, Sania Hermain, Nimbagal Raghavendra Naveen
MicroRNA Therapeutics in Cancer: Revisiting the Promise and Understanding the Limitations of Clinical Translation
Linh. T. T. Le
Gene-Driven Precision Medicine: Enhancing Biomarker Identification for Personalized Therapy
Mohamed Abbas, Abdallah Saleh, Hashim Elshafie, Mohamad Yahya H. Al-Shamri, Suresh Babu Changalasetty, Azath Mubarakali
Identification of CDKN1A as a Candidate Therapeutic Target in Peripheral Artery Disease Progression: Integrative Multi-omics and Mendelian Randomization Study
Shengquan Chen, Haotian Zhu, Chuan Zhang, Huarong Xie, Yongkang Li, Shujing Zhang, Shaoying Lu, Jun Feng, Jichang Wang
Frequently asked questions
How long does it take to publish?
Quick Track allows online publication within 2 weeks of receipt of the final approved galley proofs and 10 weeks from first receipt of the manuscript to online publication, subject to acceptance and author revisions within one week. Revised papers are usually requested within 15 days, with revision time varying from 1 to 4 weeks. Proofs should be returned within 48 hours.
Reformat to Current Gene Therapy using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to Current Gene Therapy using Livewrite PremiumWhat are the publication costs?
Publication charges are US $690 for research articles, US $190 for short communications/letters, and US $290 for review articles. Optional Gold Open Access costs US $3633 per article for general submissions and US $1900 for thematic issues.
Reformat to Current Gene Therapy using Livewrite Premium